Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2010; 16(46): 5815-5821
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5815
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5815
Table 1 Basic subject data (mean ± SD) n (%)
| UC (n = 48) | Controls (n = 47) | |
| Age (yr) | 43.49 ± 15.48 | 41.21 ± 15.36 |
| Sex (M/F) | 21 (43.8)/27 (56.2) | 21 (44.7)/26 (55.3) |
| Age at diagnosis (yr) | 35.07 ± 14.39 | |
| Disease duration (yr) | 8.42 ± 8.49 | |
| Familial disease | 0 (0) | 0 (0) |
| Disease location | ||
| Proctitis | 3 (6.25) | |
| Left colitis | 27 (56.3) | |
| Right colitis | 1 (2.1) | |
| Pancolitis | 17 (35.4) | |
| Disease severity | ||
| Light | 17 (35.4) | |
| Mild | 18 (37.5) | |
| Severe | 13 (27.1) | |
| History of colectomy | 5 (10.4) | |
| History of immunosuppressant | 6 (12.5) | |
| History of colon cancer | 3 (6.3) |
Table 2 Primers used in polymerase chain reaction for genotyping Toll-like receptor 9 polymorphisms and three single nucleotide polymorphisms
| Fragment (product) | Forward | Reverse |
| TLR9 polymorphisms | ||
| -2109 to -1293 (817 bp) | 5'-CCAAGGGACTCTGGGAAAG-3' | 5'-CATGTCACCCTCTCAACAGGG-3' |
| -1626 to -1095 (532 bp) | 5'-CAGCCTTCACTCAGAAATACCC-3' | 5'-GGCCAACAAGGCCCTATG-3' |
| -1296 to -553 (662 bp) | 5'-CATGGGAGCAGAGACATAATG-3' | 5'-GCCAGGGTGTAGCTTGA-3' |
| -795 to -134 (662 bp) | 5'-GAGTCTCCTCACCTAGATCAG-3' | 5'-TATACCAGCCTAGTAGC-3' |
| 79 to 962 (884 bp) | 5'-CTGCAAGCAACAGTGACGG-3' | 5'-AGCTTTCACTTAACCAATCCC-3' |
| -393 to 1698 (2092 bp) | 5'-TACCCGCTACTGGTGCTATC-3' | 5'-TGGCAGAGTCTAGCATCAGG-3' |
| 996 to 1687 (692 bp) | 5'-CTGGTTCTGAAGCCTAATTC-3' | 5'-AGCATGAGGATGTTGGTATGG-3' |
| 976 to 1899 (924 bp) | 5'-CTGGATTCTAGGTCTCAGTCC-3' | 5'-CTGGATTCTAGGTCTCAGTCC-3' |
| 1540 to 2368 (829 bp) | 5'-CCTGCCACATGACCATCGAG-3' | 5'-CCTGCCACATGACCATCGAG-3' |
| 1812 to 2520 (709 bp) | 5'-AACCTCACCCACCTGTCAC-3' | 5'-AACCTCACCCACCTGTCAC-3' |
| 2407 to 3350 (944 bp) | 5'-TGCAGATGAACTTCATCAACC-3' | 5'-GCTGTTGCAGCTGACATC-3' |
| 3267 to 4057 (791 bp) | 5'-CAGGAAACCAGCTGAAGG-3' | 5'-CAGGAAACCAGCTGAAGG-3' |
| 3867 to 4701 (835 bp) | 5'-GACTGGGTGTACAACGAGCTT-3' | 5'-TTCTGCATGGGAAAGGTAGG-3' |
| SNP | ||
| -1486 | 5'-CAGCCTTCACTCAGAAATACCC-3' | 5'-GGCCAACAAGGCCCTATG-3' |
| 1174 | 5'-CTGGTTCTGAAGCCTAATTC-3' | 5'-AGCATGAGGATGTTGGTATGG-3' |
| 2848 | 5'-TGCAGATGAACTTCATCAACC-3' | 5'-GCTGTTGCAGCTGACATC-3' |
Table 3 Allele frequencies in ulcerative colitis cases and disease-free controls for Toll-like receptor 9 single nucleotide polymorphisms at -1486, 1174, 2848
Table 4 Genotype frequencies in ulcerative colitis cases and disease-free controls for Toll-like receptor 9 single nucleotide polymorphisms at -1486, 1174, 2848 n (%)
Table 5 Haplotype frequencies in ulcerative colitis cases and disease-free controls for Toll-like receptor 9 single nucleotide polymorphisms at -1486, 1174, 2848 n (%)
Table 6 Diplotype frequencies in ulcerative colitis cases and disease-free controls for Toll-like receptor 9 single nucleotide polymorphisms at -1486, 1174, 2848 n (%)
Table 7 Linkage disequilibrium among single nucleotide polymorphisms of Toll-like receptor 9 in ulcerative colitis cases and disease-free controls
| SNPs | UC (n = 48) | Controls (n = 47) | |||
| |D’| | r2 | |D’| | r2 | ||
| -1486 T/C | 1174 A/G | 1 | 1 | 1 | 1 |
| -1486 T/C | 2848 G/A | 1 | 0.9522 | 1 | 0.9581 |
| 1174 A/G | 2848 G/A | 1 | 0.9522 | 1 | 0.9581 |
- Citation: Fuse K, Katakura K, Sakamoto N, Ohira H. Toll-like receptor 9 gene mutations and polymorphisms in Japanese ulcerative colitis patients. World J Gastroenterol 2010; 16(46): 5815-5821
- URL: https://www.wjgnet.com/1007-9327/full/v16/i46/5815.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i46.5815
